Show simple item record

dc.contributor.authorDombernowsky, P
dc.contributor.authorClavel, M
dc.contributor.authorSmyth, J
dc.contributor.authorHowell, Anthony
dc.contributor.authorVan Glabbeke, M
dc.contributor.authorRenard, J
dc.contributor.authorPinedo, H
dc.date.accessioned2010-11-22T17:06:33Z
dc.date.available2010-11-22T17:06:33Z
dc.date.issued1988-08
dc.identifier.citationPhase II study of TCNU in advanced breast cancer. 1988, 24 (8):1377-8 Eur J Cancer Clin Oncolen
dc.identifier.issn0277-5379
dc.identifier.pmid3181260
dc.identifier.doi10.1016/0277-5379(88)90232-5
dc.identifier.urihttp://hdl.handle.net/10541/116011
dc.language.isoenen
dc.subjectAnticancerous Agentsen
dc.subjectBreast Canceren
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAntineoplastic Agents
dc.subject.meshBreast Neoplasms
dc.subject.meshDrug Evaluation
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMiddle Aged
dc.subject.meshNitrosourea Compounds
dc.subject.meshTaurine
dc.titlePhase II study of TCNU in advanced breast cancer.en
dc.typeArticleen
dc.contributor.departmentDepartment of Oncology, Copenhagen University Hospital, Herlev, Denmark.en
dc.identifier.journalEuropean Journal of Cancer & Clinical Oncologyen


Files in this item

This item appears in the following Collection(s)

Show simple item record